TES-based cationic lipids

JP7844452B2Active Publication Date: 2026-04-13TRANSLATE BIO INC
7 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
TRANSLATE BIO INC
Filing Date
2021-09-22
Publication Date
2026-04-13

Smart Images

  • Figure 0007844452000076
    Figure 0007844452000076
  • Figure 0007844452000001
    Figure 0007844452000001
  • Figure 0007844452000002
    Figure 0007844452000002
Patent Text Reader

Abstract

The present invention provides, in part, a TES-based lipid compound of formula (Ia) and its subformulas: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful, for example, as components of liposome delivery vehicles, for the delivery and expression of mRNA and the encoded protein, and therefore can be useful for treating various diseases, disorders, and conditions, such as those associated with one or more protein deficiencies. [Formula 1] TIFF2023542945000083.tif33116
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Compounds containing cytoprotective lipid moieties

    JP1993502015A

  • Therapeutic compounds and their uses

    JP2007510662A

  • Cationic sulfonamide aminolipids and amphiphilic zwitterionic aminolipids

    JP2019519503A

  • Lipids and lipid compositions for the delivery of active agents

    WO2015095340A1

  • PH-responsive lipids

    WO2018033883A2